🟢 Chemours is trading 6.3% up in after-hours trading as Q3 EBITDA hit high end of guidance

Chemours is trading 6.3% up at $13.92 after its third-quarter update, released November 2 and discussed on November 3, with adjusted EBITDA at the high end of guidance.

• Adjusted EBITDA was $200 million, and the company expects full-year adjusted EBITDA of $775 million to $800 million.
• Adjusted EPS was $0.21, below analyst estimates, alongside continued weakness in Thermal & Specialized Solutions.